Ra Capital Management, L.P. has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $6.64 Billion distributed in 79 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ascendis Pharma A/S with a value of $1.38B, Vaxcyte, Inc. with a value of $619M, Janux Therapeutics, Inc. with a value of $384M, Legend Biotech Corp with a value of $332M, and Rhythm Pharmaceuticals, Inc. with a value of $250M.
Examining the 13F form we can see an decrease of $54.7B in the current position value, from $61.3B to 6.64B.
Ra Capital Management, L.P. is based out at Boston, MA
Below you can find more details about Ra Capital Management, L.P. portfolio as well as his latest detailed transactions.
